Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Clinical Nuclear Cardiology is the standard text for clinicians and researchers in nuclear cardiology. New developments in technology, instrumentation and radiopharmaceuticals will be addressed in the third edition of this popular text. New material on molecular imaging will help the reader to access this key area for the development of nuclear cardiology. Special population sections have been added to address the rise in patient management problems. Nuclear Cardiology is a highly visual subject that is best illustrated with four colour images. This edition will be a completely new four colour design, and will be the first in nuclear cardiology.…mehr
Clinical Nuclear Cardiology is the standard text for clinicians and researchers in nuclear cardiology. New developments in technology, instrumentation and radiopharmaceuticals will be addressed in the third edition of this popular text. New material on molecular imaging will help the reader to access this key area for the development of nuclear cardiology. Special population sections have been added to address the rise in patient management problems. Nuclear Cardiology is a highly visual subject that is best illustrated with four colour images. This edition will be a completely new four colour design, and will be the first in nuclear cardiology.
Produktdetails
- Produktdetails
- Verlag: Mosby
- 3rd ed.
- Englisch
- Gewicht: 2490g
- ISBN-13: 9780323024945
- ISBN-10: 0323024947
- Artikelnr.: 13550865
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
- Verlag: Mosby
- 3rd ed.
- Englisch
- Gewicht: 2490g
- ISBN-13: 9780323024945
- ISBN-10: 0323024947
- Artikelnr.: 13550865
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Barry L. Zaret, MD, Robert W. Berliner Professor of Medicine, Professor of Diagnostic Radiology, Chief, Section of Cardiovascular Medicine, Associate Chair for Clinical Affairs, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT;
George A. Beller, MD, Ruth C. Heede Professor of Cardiology and Professor of Medicine, University of Virginia School of Medicine; Cardiovascular Division, Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA.
George A. Beller, MD, Ruth C. Heede Professor of Cardiology and Professor of Medicine, University of Virginia School of Medicine; Cardiovascular Division, Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA.
I. Radiopharmaceuticals/Tracer KineticsOverview of Kinetics and Modeling
- Kinetics on a Cellular Level
- Role of Intact Biological Models for Evaluation of Radiotracers
II. Instrumentation
- SPECT Processing, Quantification, and Display
- SPECT Artifacts
- Attenuation/Scatter/Resolution Correction: Physics Aspects
- Attenuation/Scatter Correction: Clinical Aspects
- Dynamic Cardiac SPECT Using Fast Data Acquisition Systems
- The New Generation PET/CT Scanners: Implications for Cardiac Imaging
- State of the Art Instrumentation for PET and SPECT Imaging in Small Animals
III. Ventricular Function
- Cardiac Performance
- Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging
IV. Perfusion Imaging
- Coronary Artery Disease: Exercise Stress
- Coronary Artery Disease Detection: Pharmacologic Stress
- Prognosis Applications of Myocardial Perfusion Imaging: Exercise Stress
- Prognostic Value of Pharmacologic Stress Myocardial Perfusion Scintigraphy And Its Use In Risk Stratification
- Myocardial Perfusion Imaging Using Non-Radionuclide Techniques
- Cost Effectiveness of Myocardial Perfusion SPECT
V. Disease/Gender Specific Issues
- Imaging in Women
- Imaging for Preoperative Risk Stratification
- Nuclear Imaging in Patients with a History of Coronary Revascularization
- Stress Myocardial Pefusion Imaging in Patients with Diabetes Mellitus
- Radionuclide Imaging in Heart Failure and Cardiomyopathies
- Imaging in Patients Receiving Cardiotoxic Chemotherapy
- Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia
- Measurement of Myocardial Blood Flow and Monitoring Therapy
VI. Acute Coronary Syndromes
- Imaging Patients with Chest Pain in the Emergency Department
- Measuring the Efficacy of Therapy in Acute
- Myocardial Infarction with Technetium-99m-SESTAMIBI Imaging
- Risk Stratification After ST Elevation Acute MI
- Risk Stratification in Acute Coronary Syndromes
VII. Viability
- Physiologic and Metabolic Basis of Myocardial Viability Imaging
- Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents
- Assessment of Myocardial Viability With PET
- Comparison with Non-Nuclear Techniques
VIII. Tracer Specific Imaging Techniques
- Fatty Acid Imaging
- Cardiac Neurotransmitter Imaging: SPECT
- Cardiac Neurotransmitter Imaging: PET
- Receptor Imaging
IX. New Molecular Approaches
- New Molecular Approaches For Imaging of Angiogenesis and Hypoxia
- Noninvasive Detection of Cell Death in Myocardial Disorders
- Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to Rupture
- Molecular Imaging of Gene Products
- Imaging Myocardial Inflammation
- Section X: Mini-Atlas of Case Presentations
- Kinetics on a Cellular Level
- Role of Intact Biological Models for Evaluation of Radiotracers
II. Instrumentation
- SPECT Processing, Quantification, and Display
- SPECT Artifacts
- Attenuation/Scatter/Resolution Correction: Physics Aspects
- Attenuation/Scatter Correction: Clinical Aspects
- Dynamic Cardiac SPECT Using Fast Data Acquisition Systems
- The New Generation PET/CT Scanners: Implications for Cardiac Imaging
- State of the Art Instrumentation for PET and SPECT Imaging in Small Animals
III. Ventricular Function
- Cardiac Performance
- Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging
IV. Perfusion Imaging
- Coronary Artery Disease: Exercise Stress
- Coronary Artery Disease Detection: Pharmacologic Stress
- Prognosis Applications of Myocardial Perfusion Imaging: Exercise Stress
- Prognostic Value of Pharmacologic Stress Myocardial Perfusion Scintigraphy And Its Use In Risk Stratification
- Myocardial Perfusion Imaging Using Non-Radionuclide Techniques
- Cost Effectiveness of Myocardial Perfusion SPECT
V. Disease/Gender Specific Issues
- Imaging in Women
- Imaging for Preoperative Risk Stratification
- Nuclear Imaging in Patients with a History of Coronary Revascularization
- Stress Myocardial Pefusion Imaging in Patients with Diabetes Mellitus
- Radionuclide Imaging in Heart Failure and Cardiomyopathies
- Imaging in Patients Receiving Cardiotoxic Chemotherapy
- Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia
- Measurement of Myocardial Blood Flow and Monitoring Therapy
VI. Acute Coronary Syndromes
- Imaging Patients with Chest Pain in the Emergency Department
- Measuring the Efficacy of Therapy in Acute
- Myocardial Infarction with Technetium-99m-SESTAMIBI Imaging
- Risk Stratification After ST Elevation Acute MI
- Risk Stratification in Acute Coronary Syndromes
VII. Viability
- Physiologic and Metabolic Basis of Myocardial Viability Imaging
- Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents
- Assessment of Myocardial Viability With PET
- Comparison with Non-Nuclear Techniques
VIII. Tracer Specific Imaging Techniques
- Fatty Acid Imaging
- Cardiac Neurotransmitter Imaging: SPECT
- Cardiac Neurotransmitter Imaging: PET
- Receptor Imaging
IX. New Molecular Approaches
- New Molecular Approaches For Imaging of Angiogenesis and Hypoxia
- Noninvasive Detection of Cell Death in Myocardial Disorders
- Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to Rupture
- Molecular Imaging of Gene Products
- Imaging Myocardial Inflammation
- Section X: Mini-Atlas of Case Presentations
I. Radiopharmaceuticals/Tracer KineticsOverview of Kinetics and Modeling
- Kinetics on a Cellular Level
- Role of Intact Biological Models for Evaluation of Radiotracers
II. Instrumentation
- SPECT Processing, Quantification, and Display
- SPECT Artifacts
- Attenuation/Scatter/Resolution Correction: Physics Aspects
- Attenuation/Scatter Correction: Clinical Aspects
- Dynamic Cardiac SPECT Using Fast Data Acquisition Systems
- The New Generation PET/CT Scanners: Implications for Cardiac Imaging
- State of the Art Instrumentation for PET and SPECT Imaging in Small Animals
III. Ventricular Function
- Cardiac Performance
- Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging
IV. Perfusion Imaging
- Coronary Artery Disease: Exercise Stress
- Coronary Artery Disease Detection: Pharmacologic Stress
- Prognosis Applications of Myocardial Perfusion Imaging: Exercise Stress
- Prognostic Value of Pharmacologic Stress Myocardial Perfusion Scintigraphy And Its Use In Risk Stratification
- Myocardial Perfusion Imaging Using Non-Radionuclide Techniques
- Cost Effectiveness of Myocardial Perfusion SPECT
V. Disease/Gender Specific Issues
- Imaging in Women
- Imaging for Preoperative Risk Stratification
- Nuclear Imaging in Patients with a History of Coronary Revascularization
- Stress Myocardial Pefusion Imaging in Patients with Diabetes Mellitus
- Radionuclide Imaging in Heart Failure and Cardiomyopathies
- Imaging in Patients Receiving Cardiotoxic Chemotherapy
- Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia
- Measurement of Myocardial Blood Flow and Monitoring Therapy
VI. Acute Coronary Syndromes
- Imaging Patients with Chest Pain in the Emergency Department
- Measuring the Efficacy of Therapy in Acute
- Myocardial Infarction with Technetium-99m-SESTAMIBI Imaging
- Risk Stratification After ST Elevation Acute MI
- Risk Stratification in Acute Coronary Syndromes
VII. Viability
- Physiologic and Metabolic Basis of Myocardial Viability Imaging
- Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents
- Assessment of Myocardial Viability With PET
- Comparison with Non-Nuclear Techniques
VIII. Tracer Specific Imaging Techniques
- Fatty Acid Imaging
- Cardiac Neurotransmitter Imaging: SPECT
- Cardiac Neurotransmitter Imaging: PET
- Receptor Imaging
IX. New Molecular Approaches
- New Molecular Approaches For Imaging of Angiogenesis and Hypoxia
- Noninvasive Detection of Cell Death in Myocardial Disorders
- Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to Rupture
- Molecular Imaging of Gene Products
- Imaging Myocardial Inflammation
- Section X: Mini-Atlas of Case Presentations
- Kinetics on a Cellular Level
- Role of Intact Biological Models for Evaluation of Radiotracers
II. Instrumentation
- SPECT Processing, Quantification, and Display
- SPECT Artifacts
- Attenuation/Scatter/Resolution Correction: Physics Aspects
- Attenuation/Scatter Correction: Clinical Aspects
- Dynamic Cardiac SPECT Using Fast Data Acquisition Systems
- The New Generation PET/CT Scanners: Implications for Cardiac Imaging
- State of the Art Instrumentation for PET and SPECT Imaging in Small Animals
III. Ventricular Function
- Cardiac Performance
- Regional and Global Ventricular Function and Volumes from SPECT Perfusion Imaging
IV. Perfusion Imaging
- Coronary Artery Disease: Exercise Stress
- Coronary Artery Disease Detection: Pharmacologic Stress
- Prognosis Applications of Myocardial Perfusion Imaging: Exercise Stress
- Prognostic Value of Pharmacologic Stress Myocardial Perfusion Scintigraphy And Its Use In Risk Stratification
- Myocardial Perfusion Imaging Using Non-Radionuclide Techniques
- Cost Effectiveness of Myocardial Perfusion SPECT
V. Disease/Gender Specific Issues
- Imaging in Women
- Imaging for Preoperative Risk Stratification
- Nuclear Imaging in Patients with a History of Coronary Revascularization
- Stress Myocardial Pefusion Imaging in Patients with Diabetes Mellitus
- Radionuclide Imaging in Heart Failure and Cardiomyopathies
- Imaging in Patients Receiving Cardiotoxic Chemotherapy
- Mechanistic and Methodological Considerations for the Imaging of Mental Stress Ischemia
- Measurement of Myocardial Blood Flow and Monitoring Therapy
VI. Acute Coronary Syndromes
- Imaging Patients with Chest Pain in the Emergency Department
- Measuring the Efficacy of Therapy in Acute
- Myocardial Infarction with Technetium-99m-SESTAMIBI Imaging
- Risk Stratification After ST Elevation Acute MI
- Risk Stratification in Acute Coronary Syndromes
VII. Viability
- Physiologic and Metabolic Basis of Myocardial Viability Imaging
- Assessment of Myocardial Viability with Thallium-201 and Technetium-Based Agents
- Assessment of Myocardial Viability With PET
- Comparison with Non-Nuclear Techniques
VIII. Tracer Specific Imaging Techniques
- Fatty Acid Imaging
- Cardiac Neurotransmitter Imaging: SPECT
- Cardiac Neurotransmitter Imaging: PET
- Receptor Imaging
IX. New Molecular Approaches
- New Molecular Approaches For Imaging of Angiogenesis and Hypoxia
- Noninvasive Detection of Cell Death in Myocardial Disorders
- Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to Rupture
- Molecular Imaging of Gene Products
- Imaging Myocardial Inflammation
- Section X: Mini-Atlas of Case Presentations
